BioSphere Medical To Announce 2nd Quarter 2005 Earnings Results.ROCKLAND, Mass. -- BIOSPHERE MEDICAL, (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BSMD), the medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids Uterine Fibroids Definition Uterine fibroids (also called leiomyomas or myomas) are benign growths of the muscle inside the uterus. They are not cancerous, nor are they related to cancer. , hypervascularized tumors and vascular malformations, by occluding their blood supply, announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, July 28 at 11:00 a.m. Eastern Time (10 a.m. Central Time). The number to dial into the teleconference is 1-888-603-7990 or 1-706-679-7298 for international callers. The conference ID is 7879751. Please call in approximately ten minutes before the call is scheduled to begin. The call is also being webcast by CCBN CCBN Central Coast Bancorp CCBN Charles County Business Network and can be accessed at our web site: www.biospheremed.com. A replay of the teleconference will be available from 2:00 P.M. (ET) on July 28, 2005 through 2:00PM on August 12, 2005. The replay dial-in number is 1-800-642-1687 or 1-706-645-9291 for international callers. The code for the replay is 7879751. A replay of the webcast will be available in the investor section of our company website at www.biospheremed.com. About BioSphere Medical, Inc. BioSphere Medical, Inc., a medical device company based in Rockland, Massachusetts, pioneers and commercializes minimally invasive diagnostic and therapeutic applications based on proprietary bioengineered microsphere Not to be confused with Glass microphere. This article largely refers to micropheres or protein protocells as small spherical units postulated by some scientists as a key stage in the origin of life. technology. The Company's core technologies, patented bioengineered polymers and manufacturing methods, are used to produce microscopic spherical materials with unique beneficial properties for a variety of medical applications. BioSphere's principal focus is the treatment of symptomatic uterine fibroids using a procedure called uterine fibroid embolization Uterine Fibroid Embolization Definition Uterine fibroids are growths in the muscular tissue of the womb (uterus). Uterine fibroid embolization is non-surgical removal of the growths through the use of a tubular device called a catheter. , or UFE UFE Uterine Fibroid Embolization UFE United for a Fair Economy UFE Ufficio Federale dell'Energia UFE Uniform Final Examination UFE Urban Challenge Final Event (DARPA) UFE Unidentified Flags and Ensigns UFE Unrestricted Free Agent . The Company's products continue to gain acceptance in this rapidly emerging procedure as well as in a number of other new and established medical treatments. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion